Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0B4SF
|
||||
Former ID |
DIB020048
|
||||
Drug Name |
impromidine
|
||||
Synonyms |
SK&F-92676-A3
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [538738] | ||
Structure |
Download2D MOL |
||||
Formula |
C14H23N7S
|
||||
InChI |
InChI=1S/C14H23N7S/c1-11-13(21-10-19-11)8-22-6-5-18-14(15)17-4-2-3-12-7-16-9-20-12/h7,9-10H,2-6,8H2,1H3,(H,16,20)(H,19,21)(H3,15,17,18)
|
||||
InChIKey |
MURRAGMMNAYLNA-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Histamine H2 receptor | Target Info | Agonist | [527955] | |
Histamine H1 receptor | Target Info | Antagonist | [527955] | ||
Histamine H4 receptor | Target Info | Agonist | [527589] | ||
Histamine H3 receptor | Target Info | Agonist | [535111] | ||
WikiPathways | Monoamine GPCRs | ||||
GPCRs, Class A Rhodopsin-like | |||||
Secretion of Hydrochloric Acid in Parietal Cells | |||||
GPCR ligand binding | |||||
GPCR downstream signalingWP58:Monoamine GPCRs | |||||
IL-4 Signaling Pathway | |||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
GPCR downstream signalingWP1825:GPCR ligand binding | |||||
GPCR downstream signaling | |||||
GPCRs, OtherWP727:Monoamine Transport | |||||
References | |||||
Ref 527589 | Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist. J Pharmacol Exp Ther. 2005 Sep;314(3):1310-21. Epub 2005 Jun 9. | ||||
Ref 527955 | Probing ligand-specific histamine H1- and H2-receptor conformations with NG-acylated Imidazolylpropylguanidines. J Pharmacol Exp Ther. 2006 Apr;317(1):139-46. Epub 2006 Jan 4. | ||||
Ref 535111 | Cloning and pharmacological characterization of a fourth histamine receptor (H(4)) expressed in bone marrow. Mol Pharmacol. 2001 Mar;59(3):420-6. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.